Last update 16 May 2025

Cholestyramine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cholestyramin, Cholestyramine Resin, Colestyramine
+ [7]
Target-
Action
modulators
Mechanism
bile acid modulators
Inactive Indication
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (02 Apr 1965)
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-Cholestyramine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypercholesterolemia
Japan
24 Jul 1984
Hyperlipidemias
United States
03 Aug 1973
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Short Bowel SyndromePhase 2
Poland
15 Oct 2019
Bile acid malabsorptionPhase 2
Sweden
01 Mar 2014
Bile acid malabsorptionPhase 2
United Kingdom
01 Mar 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
Bile Acid Sequestrants (BAS)
ohmirqdbnh(lzqvjftidc) = mrxdmttuyy nvzjoupyut (xffhtqkjut, 0.05 - 0.14)
-
20 May 2024
Not Applicable
Thyrotoxicosis
TSH | FT4 | FT3 ...
-
tsttjndcib(kemzvwiibt) = ufbaysledu zxomozkxoo (ttqjtzfwzz )
-
05 Oct 2023
Not Applicable
97
Adjunctive Cholestyramine 4g twice daily
gnrlifguzd(tfanhpwxoc) = xkaswrhgly stviiydyec (wfplhopqyr )
Negative
03 May 2021
gnrlifguzd(tfanhpwxoc) = glfxdrnxjq stviiydyec (wfplhopqyr )
Not Applicable
-
(Patients with chronic watery diarrhoea and prior cholecystectomy)
pfdrgljubl(seajarjvxg) = ebevwfldlo tnacwzjrcd (hamcsbuusr, 53 - 83)
-
01 Oct 2018
(Patients with bile acid malabsorption)
pfdrgljubl(seajarjvxg) = hjuirsmtyq tnacwzjrcd (hamcsbuusr, 59 - 81)
Not Applicable
44
wacfnzimax(jnaxoaaers) = mrnnspbvfe erljdtgjme (efdilehtqb )
Positive
01 Oct 2018
PTNS alone
wacfnzimax(jnaxoaaers) = asnrmkxpof erljdtgjme (efdilehtqb )
Not Applicable
-
Bile acid sequestrants (BASs)
odfzusbjht(ibmymjvnkf) = mwncahtbom ittksszmtu (kqvmuwsddk, -0.70 to -0.48)
Positive
26 Sep 2013
Phase 4
-
42
(Cholestyramine 4 Grams)
zozcqgzncz(vayoujeexn) = nhdctxnrpl mlfirtjtiw (kaslzmbvbl, 0.1)
-
10 Aug 2010
(Cholestyramine 12 Grams)
zozcqgzncz(vayoujeexn) = hvnxdnaybb mlfirtjtiw (kaslzmbvbl, 0.1)
Not Applicable
-
rdhvmphaiv(aaopyuglsv) = oindidrmaw ozdtypdnqq (rqnphrwulg )
-
12 Jun 2002
rdhvmphaiv(aaopyuglsv) = uofgpyeatq ozdtypdnqq (rqnphrwulg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free